Dynamic Technology Lab Private LTD Verastem, Inc. Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $11,263 - $22,314	-10,626 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $21,783 - $34,003	10,626 New	10,626 $22,000
Q4 2019 Feb 14, 2020	SELL	$0.86 - $1.44 $11,998 - $20,090	-13,952 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.59 $5,301 - $6,965	-4,381 Reduced 23.9%	13,952 $17,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $25,023 - $62,859	-20,019 Reduced 52.2%	18,333 $28,000
Q1 2019 May 13, 2019	BUY	$2.79 - $4.09 $22,741 - $33,337	8,151 Added 26.99%	38,352 $114,000
Q4 2018 Feb 13, 2019	SELL	$3.23 - $7.01 $128,127 - $278,072	-39,668 Reduced 56.77%	30,201 $102,000
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $479,301 - $696,593	69,869 New	69,869 $507,000
Q1 2018 May 14, 2018	SELL	$2.92 - $3.81 $114,402 - $149,271	-39,179 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$2.99 - $4.85 $117,145 - $190,018	39,179	39,179 $120,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.